Breaking the permeability barrier of Escherichia coli by controlled Hyperporination of the outer membrane

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 12, 2016, Pages 7372-7381

  Krishnamoorthy, Ganesh ^a   Wolloscheck, David ^a   Weeks, Jon W ^a   Croft, Cameron ^a   Rybenkov, Valentin V ^a   Zgurskaya, Helen I ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLOXACILLIN; COUMAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINCOMYCIN; NALIDIXIC ACID; NOVOBIOCIN; PROFLAVINE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TRICLOSAN; VANCOMYCIN; VIRGINIAMYCIN; ANTIINFECTIVE AGENT; ARABINOSE; OUTER MEMBRANE PROTEIN; PORIN; RECOMBINANT PROTEIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENETICS; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG UPTAKE; ESCHERICHIA COLI; GENETIC BACKGROUND; HYDROPHILICITY; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR PORE; PERMEABILITY BARRIER; PRIORITY JOURNAL; BACTERIUM TRANSFORMATION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG EFFECTS; GENE; GENE EXPRESSION; GENETIC ENGINEERING; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PLASMID; PROMOTER REGION; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; ARABINOSE; BACTERIAL OUTER MEMBRANE PROTEINS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; ERYTHROMYCIN; ESCHERICHIA COLI; GENE EXPRESSION; GENES, MDR; GENETIC ENGINEERING; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PORINS; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; TRANSFORMATION, BACTERIAL; VANCOMYCIN;

EID: 84996550733     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01882-16     Document Type: Article

References (37)

1. Zgurskaya HI, Lopez CA, Gnanakaran S. 2015. Permeability barrier of gram-negative cell envelopes and approaches to bypass it. ACS Infect Dis 1:512-522. http://dx.doi.org/10.1021/acsinfecdis.5b00097.
2. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593-656. http://dx.doi.org/10.1128/MMBR.67.4.593-656.2003.
3. Nikaido H, Pagès J-M. 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36:340-363. http://dx.doi.org/10.1111/j.1574-6976.2011.00290.x.
4. Nikaido H, Rosenberg EY, Foulds J. 1983. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol 153:232-240.
5. Plésiat P, Nikaido H. 1992. Outer membranes of Gram-negative bacteria are permeable to steroid probes. Mol Microbiol 6:1323-1333. http://dx.doi.org/10.1111/j.1365-2958.1992.tb00853.x.
6. Nikaido H, Vaara M. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1-32.
7. Nikaido H, Zgurskaya HI. 2001. AcrAB and related multidrug efflux pumps of Escherichia coli. J Mol Microbiol Biotechnol 3:215-218.
8. Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, Venter H, Chiu W, Luisi BF. 2014. Structure of the AcrAB-TolC multidrug efflux pump. Nature 509:512-515. http://dx.doi.org/10.1038/nature13205.
9. Tikhonova EB, Yamada Y, Zgurskaya HI. 2011. Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. Chem Biol 18:454-463. http://dx.doi.org/10.1016/j.chembiol.2011.02.011.
10. Sulavik MC, Houseweart C, Cramer C, Jiwani N, Murgolo N, Greene J, DiDomenico B, Shaw KJ, Miller GH, Hare R, Shimer G. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45:1126-1136. http://dx.doi.org/10.1128/AAC.45.4.1126-1136.2001.
11. Eaves DJ, Ricci V, Piddock LJ. 2004. Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob Agents Chemother 48:1145-1150. http://dx.doi.org/10.1128/AAC.48.4.1145-1150.2004.
12. Lau SY, Zgurskaya HI. 2005. Cell division defects in Escherichia coli deficient in the multidrug efflux transporter AcrEF-TolC. J Bacteriol 187:7815-7825. http://dx.doi.org/10.1128/JB.187.22.7815-7825.2005.
13. Zgurskaya HI, Krishnamoorthy G, Ntreh A, Lu S. 2011. Mechanism and function of the outer membrane channel TolC in multidrug resistance and physiology of enterobacteria. Front Microbiol 2:189. http://dx.doi.org/10.3389/fmicb.2011.00189.
14. Tal N, Schuldiner S. 2009. A coordinated network of transporters with overlapping specificities provides a robust survival strategy. Proc Natl Acad Sci U S A 106:9051-9056. http://dx.doi.org/10.1073/pnas.0902400106.
15. Pages JM, James CE, Winterhalter M. 2008. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 6:893-903. http://dx.doi.org/10.1038/nrmicro1994.
16. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol Rev 56:395-411.
17. Vuorio R, Vaara M. 1992. The lipid A biosynthesis mutation lpxA2 of Escherichia coli results in drastic antibiotic supersusceptibility. Antimicrob Agents Chemother 36:826-829. http://dx.doi.org/10.1128/AAC.36.4.826.
18. Manchester JI, Buurman ET, Bisacchi GS, McLaughlin RE. 2012. Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery. J Med Chem 55:2532-2537. http://dx.doi.org/10.1021/jm201275d.
19. Klebba PE, Newton SM. 1998. Mechanisms of solute transport through outer membrane porins: burning down the house. Curr Opin Microbiol 1:238-247. http://dx.doi.org/10.1016/S1369-5274(98)80017-9.
20. Braun M, Killmann H, Maier E, Benz R, Braun V. 2002. Diffusion through channel derivatives of the Escherichia coli FhuA transport protein. Eur J Biochem 269:4948-4959. http://dx.doi.org/10.1046/j.1432-1033.2002.03195.x.
21. Mohammad MM, Howard KR, Movileanu L. 2011. Redesign of a plugged beta-barrel membrane protein. J Biol Chem 286:8000-8013. http://dx.doi.org/10.1074/jbc.M110.197723.
22. Tikhonova EB, Wang Q, Zgurskaya HI. 2002. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria. J Bacteriol 184:6499-6507. http://dx.doi.org/10.1128/JB.184.23.6499-6507.2002.
23. Cox G, Koteva K, Wright GD. 2014. An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria. J Antimicrob Chemother 69:1844-1855. http://dx.doi.org/10.1093/jac/dku057.
24. Elkins CA, Nikaido H. 2002. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominately by two large periplasmic loops. J Bacteriol 184:6490-6498. http://dx.doi.org/10.1128/JB.184.23.6490-6499.2002.
25. Krishnamoorthy G, Tikhonova EB, Dhamdhere G, Zgurskaya HI. 2013. On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein. Mol Microbiol 87:982-997. http://dx.doi.org/10.1111/mmi.12143.
26. Choi KH, Gaynor JB, White KG, Lopez C, Bosio CM, Karkhoff-Schweizer RR, Schweizer HP. 2005. A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2:443-448. http://dx.doi.org/10.1038/nmeth765.
27. Choi K-H, Schweizer HP. 2006. Mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat Protoc 1:153-161. http://dx.doi.org/10.1038/nprot.2006.24.
28. Tikhonova EB, Zgurskaya HI. 2004. AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J Biol Chem 279:32116-32124. http://dx.doi.org/10.1074/jbc.M402230200.
29. Hancock RE. 1981. Aminoglycoside uptake and mode of action - with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J Antimicrob Chemother 8:429-445.
30. Loh B, Grant C, Hancock RE. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 26:546-551. http://dx.doi.org/10.1128/AAC.26.4.546.
31. Kojima S, Nikaido H. 2013. Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspecific channels. Proc Natl Acad Sci U S A 110:E2629-E2634. http://dx.doi.org/10.1073/pnas.1310333110.
32. Pos KM. 2009. Drug transport mechanism of the AcrB efflux pump. Biochim Biophys Acta 1794:782-793. http://dx.doi.org/10.1016/j.bbapap.2008.12.015.
33. Takatsuka Y, Chen C, Nikaido H. 2010. Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci USA 107:6559-6565. http://dx.doi.org/10.1073/pnas.1001460107.
34. Nakashima R, Sakurai K, Yamasaki S, Nishino K, Yamaguchi A. 2011. Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480:565-569. http://dx.doi.org/10.1038/nature10641.
35. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
36. Dhamdhere G, Zgurskaya HI. 2010. Metabolic shutdown in Escherichia coli cells lacking the outer membrane channel TolC. Mol Microbiol 77:743-754. http://dx.doi.org/10.1111/j.1365-2958.2010.07245.x.
37. Rosner JL, Martin RG. 2013. Reduction of cellular stress by TolC-dependent efflux pumps in Escherichia coli indicated by BaeSR and CpxARP activation of spy in efflux mutants. J Bacteriol 195:1042-1050. http://dx.doi.org/10.1128/JB.01996-12.